Alx Oncology Holdings Inc [ALXO] stock is trading at $1.79, down -1.10%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ALXO shares have gain 10.49% over the last week, with a monthly amount glided 14.74%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alx Oncology Holdings Inc [NASDAQ: ALXO] stock has seen the most recent analyst activity on December 19, 2024, when Jefferies downgraded its rating to a Hold and also revised its price target to $2 from $12. Previously, Stifel downgraded its rating to Hold on March 08, 2024, and elevated its price target to $14. On December 08, 2023, upgrade upgraded it’s rating to Buy and revised its price target to $18 on the stock. Jefferies downgraded its rating to a Hold and decreased its price target to $25 on December 22, 2021. Stifel initiated its recommendation with a Buy and recommended $106 as its price target on September 30, 2021.
Alx Oncology Holdings Inc [ALXO] stock has fluctuated between $1.19 and $17.83 over the past year. Currently, Wall Street analysts expect the stock to reach $24.5 within the next 12 months. Alx Oncology Holdings Inc [NASDAQ: ALXO] shares were valued at $1.79 at the most recent close of the market. An investor can expect a potential return of 1268.72% based on the average ALXO price forecast.
Analyzing the ALXO fundamentals
Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at -64.47%, Pretax Profit Margin comes in at -60.95%, and Net Profit Margin reading is -60.95%. To continue investigating profitability, this company’s Return on Assets is posted at -0.81, Equity is -0.93 and Total Capital is -1.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.7473 points at the first support level, and at 1.7047 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.8453, and for the 2nd resistance point, it is at 1.9007.
Ratios To Look Out For
For context, Alx Oncology Holdings Inc’s Current Ratio is 4.82. Also, the Quick Ratio is 4.82, while the Cash Ratio stands at 0.5.
Transactions by insiders
Recent insider trading involved Pinto Shelly, Interim CFO, that happened on Dec 30 ’24 when 1426.0 shares were sold. PRESIDENT & CSO, Pons Jaume completed a deal on Dec 30 ’24 to sell 10796.0 shares. Meanwhile, Director Hemrajani Rekha bought 30000.0 shares on Dec 02 ’24.
